Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors
Clinical trial NCT03895684 · COMPLETED
Trial details
- NCT number
- NCT03895684
- Sponsor
- Salarius Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2021-04-13
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.